Asthma Studies at The Lung Institute of Western Australia
The Lung Institute of Western Australia is currently recruiting asthma patients for a placebo-controlled phase III trial, testing the efficacy of a monoclonal antibody in reducing airway inflammation and disease severity. The one year study is followed by a two year open-label phase.
To help recruit patients into the study we are seeking volunteers aged 18-75 years to please contact Meagan Shorten, 9346 4964, or email: firstname.lastname@example.org
If you would like to know more about the trial and The Lung Institute of Western Australia please visit our website: www.liwa.uwa.edu.au